Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q2 pre-tax loss widens to SEK 18.0 mln

Aug 22 (Reuters) - KANCERA AB  KANC.ST : 
    * Q2 OPERATING LOSS SEK 18.0 MILLION VERSUS LOSS SEK 5.5 
MILLION YEAR AGO 
    * Q2 PRE-TAX LOSS SEK 18.0 MILLION VERSUS LOSS SEK 5.5 
MILLION YEAR AGO 
 
Source text for Eikon:  ID:nWkrbLst5Z  
Further company coverage:  KANC.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Novakand Pharma AB

See all news